Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

573
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
573
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

638
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
638
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

441
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
441
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

942
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
942

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision Medicine for Lipids: The New US Guidelines for Dyslipidemia.

Clinical chemistry·2026
Same author

Establishment and functional analysis of an inducible Apoc2-knockout mouse model to investigate the role of Apoc2 in normal hematopoiesis.

Lab animal·2026
Same author

Measurement of low-density lipoprotein cholesterol and other circulating lipids in Brazil: a systematic literature review.

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

High-Density Lipoprotein-Specific Phospholipid Efflux (HDL-SPE) Assay in Mice.

Molecular nutrition & food research·2026
Same author

In Reply to Inter-Instrument Imprecision Complements Bias in Evaluating LDL-C Method Performance.

Clinical chemistry·2026
Same author

Corrigendum to "Identification of a novel apoB variant in a family exhibiting hypocholesterolemia: Mechanistic insights" [J Clin Lipidol (2026) S1933-2874(26)00045-0, ahead of print].

Journal of clinical lipidology·2026

Related Experiment Video

Updated: Mar 22, 2026

Author Spotlight: Effect of Left Atrial Ligation on Avian Embryonic Hearts and HLHS Implications
04:37

Author Spotlight: Effect of Left Atrial Ligation on Avian Embryonic Hearts and HLHS Implications

Published on: June 16, 2023

1.8K

JCL Roundtable: Should we treat elevations in Lp(a)?

W Virgil Brown1, Patrick M Moriarty2, Alan T Remaley3

  • 1Emeritus College, Emory University School of Medicine, Atlanta, GA, USA.

Journal of Clinical Lipidology
|April 9, 2016
PubMed
Summary

High levels of lipoprotein(a) [Lp(a)] significantly increase vascular disease risk. This discussion addresses challenges in measuring Lp(a) and effective treatments for managing this cardiovascular risk factor.

Keywords:
LDL-CholesterolLipoproteinLp(a)PharmacotherapyVascular disease

More Related Videos

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

1.0K
Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
08:17

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery

Published on: February 20, 2017

15.1K

Related Experiment Videos

Last Updated: Mar 22, 2026

Author Spotlight: Effect of Left Atrial Ligation on Avian Embryonic Hearts and HLHS Implications
04:37

Author Spotlight: Effect of Left Atrial Ligation on Avian Embryonic Hearts and HLHS Implications

Published on: June 16, 2023

1.8K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

1.0K
Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
08:17

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery

Published on: February 20, 2017

15.1K

Area of Science:

  • Cardiovascular Medicine
  • Lipidology
  • Clinical Risk Assessment

Background:

  • Lipoprotein(a) [Lp(a)] is a significant, yet complex, risk factor for vascular disease.
  • Elevated plasma Lp(a) concentrations are linked to increased cardiovascular risk.
  • Individual Lp(a) levels are highly variable but stable within a person.

Purpose of the Study:

  • To address key clinical questions surrounding lipoprotein(a) [Lp(a)] as a treatment target.
  • To clarify measurement methodologies and effective reduction strategies for Lp(a).
  • To explore the relationship between Lp(a), low-density lipoprotein-cholesterol (LDL-C), and residual cardiovascular risk.

Main Methods:

  • Roundtable discussion format with leading experts in the field.
  • Expert panel addressing critical questions on Lp(a) measurement and management.
  • Review of current evidence and emerging therapies for Lp(a) reduction.

Main Results:

  • Discussion highlights the complexities in obtaining meaningful Lp(a) measurements.
  • Exploration of various agents and their effectiveness in lowering Lp(a) levels.
  • Consideration of whether Lp(a) reduction directly impacts vascular risk and residual risk after LDL-C lowering.

Conclusions:

  • Definitive management strategies for lipoprotein(a) [Lp(a)] remain a clinical challenge.
  • Further research is needed to establish optimal Lp(a) targets and effective therapies.
  • Understanding the interplay between Lp(a) and LDL-C is crucial for comprehensive cardiovascular risk management.